1. |
中华人民共和国国家卫生健康委员会医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2020年版). 中国实用外科杂志, 2020, 40(6): 601-625.
|
2. |
艾潇琳, 汪晓东, 李立. 大肠癌新辅助化疗疗效评价方法的研究进展. 胃肠病学和肝病学杂志, 2015, 24(7): 773-776.
|
3. |
汪晓东, 由屹先, 余其澳, 等. 数据库建设第九部分: 结直肠癌新辅助治疗的标签与结构化. 中国普外基础与临床杂志, 2021, 28(6): 799-804.
|
4. |
Sarasqueta C, Perales A, Escobar A, et al. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage Ⅲ colon or stage Ⅱ/Ⅲ rectal cancer. BMC Cancer, 2019, 19(1): 735. doi: 10.1186/s12885-019-5910-z.
|
5. |
He F, Chen M, Xiao WW, et al. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision. Jpn J Clin Oncol, 2021, 51(9): 1391-1399.
|
6. |
Tandon P, Reddy KR, O’Leary JG, et al. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology, 2017, 65(1): 217-224.
|
7. |
Yu Y, Carey M, Pollett W, et al. The long-term survival characteristics of a cohort of colorectal cancer patients and baseline variables associated with survival outcomes with or without time-varying effects. BMC Med, 2019, 17(1): 150. doi: 10.1186/s12916-019-1379-5.
|
8. |
汪晓东, 曾天芳, 杨妍姣, 等. 多学科协作诊治模式下老年结直肠癌患者应用新辅助化疗联合手术治疗的临床效果. 中国普外基础与临床杂志, 2008, 15(10): 773-777.
|
9. |
Sugimoto K, Sakamoto K, Ii Y, et al. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis. BMC Surg, 2021, 21(1): 188. doi: 10.1186/s12893-021-01193-4.
|
10. |
Horvat N, Veeraraghavan H, Khan M, et al. MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology, 2018, 287(3): 833-843.
|
11. |
Sanoff HK, Carpenter WR, Stürmer T, et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol, 2012, 30(21): 2624-2634.
|
12. |
韩潞, 江勇, 谭卫林. CEA和CA19-9在结直肠癌组织中的表达及临床意义. 实用癌症杂志, 2015, 30(1): 25-27.
|
13. |
惠菲菲, 刘凯, 范明明, 等. 伴有肝转移的结直肠癌患者血清CEA、CA199的分析. 中华结直肠疾病电子杂志, 2015, 4(4): 47-52.
|
14. |
李会平, 代爱军. 结直肠癌患者术前血清癌胚抗原及糖类抗原19-9阳性与临床病理学特征的关系. 中国肛肠病杂志, 2019, 39(1): 1-3.
|
15. |
李旺林, 曹杰, 唐伟镖. 血清CEA检测在结直肠癌患者中的临床意义. 热带医学杂志, 2005, 5(2): 179-181.
|
16. |
刘昕, 刘骞. 结直肠癌患者术前血清CA19-9、CEA、TPS水平与临床病理因素的相关性分析. 中华结直肠疾病电子杂志, 2013, 2(5): 230-233.
|
17. |
王静, 袁玉军. 术前CEA、D-二聚体、纤维蛋白原与结直肠癌临床病理特点、分期及预后相关性研究. 国际检验医学杂志, 2019, 40(6): 690-693.
|
18. |
杨松海, 邓跃华, 刘传磊, 等. HSP gp96和CEA在结直肠癌中的表达及临床意义的研究. 安徽医药, 2012, 16(10): 1444-1446.
|